Search - tctmd.com

Displaying 1 - 20 of 121

Sort: Relevancy | Date

News Daily News

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Michael O'Riordan

June 04, 2025

News Daily News

ACC/AHA Release New Comprehensive ACS Guidelines

Todd Neale

February 27, 2025

News Daily News

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

Yael L. Maxwell

September 23, 2024

News Daily News

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Yael L. Maxwell

June 20, 2024

News Daily News

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Michael O'Riordan

May 02, 2024

News Daily News

No Benefit to P2Y12 Inhibitor Pretreatment in STEMI, Bern-PCI Data Confirm

Yael L. Maxwell

January 10, 2024

News Daily News

CABG and PCI Comparable in ACS Patients With Left Main CAD

Michael O'Riordan

June 06, 2023

News Daily News

Shifting Acute MI Outcomes by Medicare Type: A Window Into Insurer’s Influence

L.A. McKeown

December 09, 2022

News Daily News

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Yael L. Maxwell

November 21, 2022

News Daily News

Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities

Michael O'Riordan

April 25, 2022

News Daily News

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Yael L. Maxwell

December 24, 2021

News Daily News

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

Shelley Wood

December 22, 2021

News Daily News

Tocilizumab Improves Myocardial Salvage After STEMI: ASSAIL-MI

Michael O'Riordan

April 12, 2021

News Daily News

MI Hospitalizations Down 20% at COVID-19 Peak in Italy, With a Heavy Cost

Michael O'Riordan

March 04, 2021

News Daily News

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

Michael O'Riordan

March 01, 2021

News Daily News

More Women Than Men Develop HF or Die After STEMI

L.A. McKeown

December 01, 2020

News Daily News

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

Michael O'Riordan

November 03, 2020

News Daily News

Early Revascularization in NSTEMI Linked to Lower Mortality: AHRQ Analysis

Michael O'Riordan

August 20, 2020

News Daily News

Injectable P2Y12 Inhibitor Selatogrel Shows Promise in Acute MI

Yael L. Maxwell

June 03, 2020

News Daily News

More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California

Shelley Wood

May 22, 2020

Advertisement

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

ACC/AHA Release New Comprehensive ACS Guidelines

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

No Benefit to P2Y12 Inhibitor Pretreatment in STEMI, Bern-PCI Data Confirm

CABG and PCI Comparable in ACS Patients With Left Main CAD

Shifting Acute MI Outcomes by Medicare Type: A Window Into Insurer’s Influence

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

Tocilizumab Improves Myocardial Salvage After STEMI: ASSAIL-MI

MI Hospitalizations Down 20% at COVID-19 Peak in Italy, With a Heavy Cost

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

More Women Than Men Develop HF or Die After STEMI

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

Early Revascularization in NSTEMI Linked to Lower Mortality: AHRQ Analysis

Injectable P2Y12 Inhibitor Selatogrel Shows Promise in Acute MI

More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content